Trauma refers to an event, series of events, or set of circumstances that is experienced as physically or emotionally harmful or life-threatening and has lasting adverse effects on functioning. Trauma is pervasive — most people experience at least one traumatic event in their lifetime. While most recover naturally, a significant minority develops post-traumatic stress disorder or other trauma-related conditions.
Types and Prevalence
Types of trauma. Acute trauma is a single, time-limited event (accident, assault, natural disaster). Chronic trauma involves repeated, prolonged events (ongoing abuse, domestic violence, war). Complex trauma involves multiple, varied, and usually interpersonal events, typically beginning in childhood (chronic child abuse and neglect, repeated exposure to violence). Vicarious or secondary trauma results from exposure to others trauma through professional or personal relationships.
Prevalence. Approximately 70% of adults worldwide have experienced at least one traumatic event. Lifetime PTSD prevalence is 6–8% in the general population, but rates are much higher in specific populations: 15–30% in military veterans, 30–50% in survivors of interpersonal violence, and 50–90% in survivors of sexual assault. Most trauma-exposed individuals do not develop PTSD — resilience is the norm.
Post-Traumatic Stress Disorder (PTSD)
PTSD is a psychiatric disorder that may develop after exposure to actual or threatened death, serious injury, or sexual violence. DSM-5 criteria require exposure to trauma through direct experience, witnessing in person, learning that it happened to a close family member or friend, or repeated or extreme exposure to aversive details (as in first responders).
Symptom Clusters
Intrusion symptoms. Recurrent, involuntary, and intrusive distressing memories of the traumatic event, traumatic nightmares, flashbacks (dissociative reactions in which the individual feels as if the trauma is recurring), and intense psychological or physiological distress in response to trauma reminders.
Avoidance. Persistent avoidance of internal reminders (thoughts, feelings, memories) and external reminders (people, places, activities, situations) associated with the trauma. Avoidance maintains PTSD by preventing extinction learning.
Negative alterations in cognition and mood. Inability to remember important aspects of the trauma, persistent negative beliefs about oneself or the world, distorted blame of self or others, persistent negative emotional state (fear, horror, anger, guilt, shame), diminished interest in significant activities, feeling detached from others, and inability to experience positive emotions.
Alterations in arousal and reactivity. Irritable behavior and angry outbursts, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, difficulty concentrating, and sleep disturbance.
Dissociative Subtype
A significant minority of individuals with PTSD experience depersonalization (feelings of being detached from one’s own mind or body) or derealization (feelings of unreality of the surrounding world). This subtype is associated with more severe childhood trauma, higher symptom severity, and poorer treatment response.
Neurobiology of PTSD
The stress response systems become dysregulated in PTSD. The amygdala is hyperreactive to threat-related stimuli, leading to exaggerated fear responses. The medial prefrontal cortex (mPFC) — which normally inhibits the amygdala — is hypoactive, resulting in impaired fear extinction. The hippocampus — which encodes context and distinguishes safe from dangerous environments — is atrophied, contributing to contextual fear generalization. The HPA axis shows altered cortisol patterns (often low cortisol with enhanced negative feedback), which may facilitate the development of PTSD after trauma. Hyperactivity of the noradrenergic system contributes to hyperarousal, hypervigilance, and re-experiencing symptoms.
Risk and Protective Factors
Pre-trauma factors. Female sex (2× risk), younger age at trauma, lower socioeconomic status, lower education, history of prior trauma (especially childhood abuse), pre-existing mental health conditions (anxiety, depression), family history of psychopathology, and lower cognitive ability.
Peri-trauma factors. Trauma severity, perceived life threat, peritraumatic dissociation (feeling unreal or detached during the event), and interpersonal trauma (especially by a caregiver) increase risk.
Post-trauma factors. Lack of social support, ongoing life stress, additional traumatic events, and maladaptive coping (avoidance, substance use) increase risk and impair recovery.
Evidence-Based Treatments
Trauma-focused psychotherapies are first-line treatments and are superior to medication.
Prolonged exposure therapy (PE). Teaches the patient to approach trauma-related memories, feelings, and situations that have been avoided. Components: imaginal exposure (revisiting and recounting the trauma memory), in vivo exposure (approaching safe situations that trigger trauma-related distress), and breathing retraining. PE reduces avoidance and promotes emotional processing.
Cognitive processing therapy (CPT). Focuses on identifying and challenging maladaptive beliefs about the trauma and its aftermath — particularly beliefs about safety, trust, power/control, esteem, and intimacy. Through written accounts and Socratic dialogue, patients learn to reframe the trauma in a more adaptive way.
Eye movement desensitization and reprocessing (EMDR). Involves recalling the trauma while engaging in bilateral stimulation (typically eye movements) under therapist guidance. EMDR has been controversial due to uncertainty about the mechanism of bilateral stimulation, but meta-analyses confirm that it is as effective as PE and CPT.
Pharmacotherapy. SSRIs (sertraline, paroxetine) and the SNRI venlafaxine are FDA-approved for PTSD. They are less effective than trauma-focused therapy but are important options when psychotherapy is unavailable or declined. Prazosin, once recommended for trauma nightmares, has mixed evidence in recent trials.
Complex PTSD
Complex PTSD (CPTSD) — included in ICD-11 — results from prolonged, repeated trauma, typically in childhood, from which escape is difficult or impossible. It includes the three core PTSD symptom clusters plus three additional domains: affect dysregulation (emotional volatility, difficulty calming), negative self-concept (feeling worthless, defeated, damaged), and disturbances in relationships (difficulty trusting, feeling close to others). CPTSD requires a phased treatment approach: stabilization and safety first, trauma processing second, and reintegration third.
Summary
Trauma is a common human experience, but only a minority of those exposed develop PTSD. The disorder involves four symptom clusters: intrusion, avoidance, negative alterations in cognition and mood, and hyperarousal. Fear conditioning, impaired extinction learning, and hippocampal and prefrontal dysfunction underlie the neurobiology. Trauma-focused psychotherapies — PE, CPT, and EMDR — are the most effective treatments. Complex PTSD, arising from prolonged early-life trauma, requires a phased treatment approach. Post-traumatic growth, while not diminishing the reality of trauma, acknowledges the potential for positive transformation.